drugset / Trial / NCT02461056

Synergistic Effect of Ibuprofen and Hydromorphone for Postoperative Pain

NCT02461056

Completed 90 enrolled Samsung Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Intravenous form of ibuprofen is recently approved by FDA and reports are rare on the co-administration with opioids. The investigators searched whether intravenous ibuprofen-hydromorphone combination is synergistic, additive, or infra-additive on postoperative pain using combination index (CI), dose reduction index (DRI) and isobologram.

Timeline

Start
2014-06
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydromorphone Other / unclassified 0.125 mg Intravenous
Comparator Hydromorphone Other / unclassified 0.25 mg Intravenous
Comparator Hydromorphone Other / unclassified 0.5 mg Intravenous
Comparator Hydromorphone Other / unclassified 0.75 mg Intravenous
Comparator Hydromorphone Other / unclassified 1 mg Intravenous
Comparator Hydromorphone Other / unclassified 1.5 mg Intravenous
Comparator Hydromorphone Other / unclassified 2 mg Intravenous
Comparator Ibuprofen Small molecule 25 mg Intravenous
Comparator Ibuprofen Small molecule 50 mg Intravenous
Comparator Ibuprofen Small molecule 100 mg Intravenous
Comparator Ibuprofen Small molecule 200 mg Intravenous
Comparator Ibuprofen Small molecule 400 mg Intravenous
Comparator Ibuprofen Small molecule 800 mg Intravenous

Indications